Abingdon Health Plc

LSE ABDX.L

Abingdon Health Plc Debt to Equity Ratio for the year ending June 30, 2024: 0.47

Abingdon Health Plc Debt to Equity Ratio is 0.47 for the year ending June 30, 2024, a 37.73% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Abingdon Health Plc Debt to Equity Ratio for the year ending June 30, 2023 was 0.34, a 70.17% change year over year.
Abingdon Health Plc Debt to Equity Ratio for the year ending June 30, 2022 was 0.20, a 183.89% change year over year.
Abingdon Health Plc Debt to Equity Ratio for the year ending June 30, 2021 was 0.07, a -95.96% change year over year.
Abingdon Health Plc Debt to Equity Ratio for the year ending June 30, 2020 was 1.74, a 1,997.78% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

LSE: ABDX.L

Abingdon Health Plc

CEO	Mr. Chris Henry Francis Yates
IPO Date	Dec. 15, 2020
Location	United Kingdom
Headquarters	York Biotech Campus
Employees	84
Sector	Health Care
Industries Pharmaceuticals Biotechnology Medical Instruments

Description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Key trends

Past 5 years